Home > Products > CD20 & CD3
> Recombinant Anti-CD20 x Anti-CD3 Bispecific Antibody (BsIgG)
Recombinant Anti-CD20 x Anti-CD3 Bispecific Antibody (BsIgG) (CAT#: KN-0422-LN12)
Recombinant Anti-CD20 x Anti-CD3 Bispecific Antibody (BsIgG) is designed to be expressed as four chains with Fc mutations to form heterodimers. It has the general size and structure of a conventional IgG. The Fc region also engineered to decrease Fc-mediated functions, but remains the half-life. This BsAb can retarget T cells to tumor cells. It is designed for the research of Lymphoma therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD20 x Anti-CD3 Bispecific Antibody (BsIgG) (KN-0422-LN12). Click the button below to contact us or submit your feedback about this product.